Stone Ridge Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-16,000
Closed -$3.1M 944
2019
Q3
$3.1M Hold
16,000
0.19% 104
2019
Q2
$2.95M Buy
+16,000
New +$2.86M 0.17% 115
2016
Q2
Sell
-3,100
Closed -$465K 8
2016
Q1
$465K Hold
3,100
2.82% 3
2015
Q4
$503K Hold
3,100
1.7% 5
2015
Q3
$429K Hold
3,100
1.7% 9
2015
Q2
$476K Hold
3,100
1.1% 13
2015
Q1
$496K Hold
3,100
1.24% 8
2014
Q4
$494K Buy
+3,100
New +$483K 1.04% 4

Other funds holding AMGN

Stone Ridge Asset Management's AMGN Position: Q4 2019 in Review

Stone Ridge Asset Management sold out of Amgen (AMGN) in Q4 2019, closing a stake of 16,000 shares — an estimated $3.1M sold.

Stone Ridge Asset Management first reported a position in AMGN in Q4 2014 and held it in 8 quarters. The position peaked at $3.1M in Q3 2019. 2,107 funds tracked by Wall St. Rank hold AMGN as of Q4 2019.

  • Stone Ridge Asset Management reported no remaining Amgen position as of Q4 2019 after selling out during the quarter.
  • Stone Ridge Asset Management sold 16,000 Amgen shares in Q4 2019, an estimated $3.1M.
  • Stone Ridge Asset Management first reported a position in Amgen in Q4 2014 and held it in 8 quarters.
  • Stone Ridge Asset Management's Amgen position peaked at $3.1M in Q3 2019.
  • 2,107 funds tracked by Wall St. Rank held Amgen as of Q4 2019.

Based on Stone Ridge Asset Management's 13F filing for Q4 2019, filed 6 Feb 2020.